Tuberculosis patients with higher levels of poverty face equal or greater costs of illness
OBJECTIVE: To evaluate the association between tuberculosis (TB) patient costs and poverty as measured by a multidimensional poverty index.
DESIGN: We performed cross-sectional interviews of consecutive patients with TB. TB episode costs were estimated from self-reported income, travel costs, and care-seeking time. Poverty was assessed using the South African Multidimensional Poverty Index (SAMPI) deprivation score (a 12-item household-level index), with higher scores indicating greater poverty. We used multivariable linear regression to adjust for age, sex, human immunodeficiency virus status and travel time.
RESULTS: Among 323 participants, 108 (33%) were ‘deprived' (deprivation score >0.33). For each 0.1-unit increase in deprivation score, absolute TB episode costs were 1.11 times greater (95%CI 0.97–1.26). TB episode costs were 1.19 times greater with each quintile of higher deprivation score (95%CI 1.00–1.40), but lower by a factor of 0.54 with each quintile of lower self-reported income (higher poverty, 95%CI 0.46–0.62).
CONCLUSION: Individuals experiencing multidimensional poverty and the cost of tuberculosis illness in Limpopo, South Africa faced equal or higher costs of TB than non-impoverished patients. Individuals with lower self-reported income experienced higher costs as a proportion of household income but lower absolute costs. Targeted interventions are needed to reduce the economic burden of TB on patients with multidimensional poverty.
Keywords: income; multidimensional poverty index; patient costs
Document Type: Research Article
Affiliations: 1: School of Medicine, Johns Hopkins University, Baltimore 2: Department of Epidemiology 3: Department of Epidemiology International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA 4: Perinatal HIV Research Unit, Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, University of the Witwatersrand, South Africa 5: Perinatal HIV Research Unit, Soweto Matlosana Collaborating Centre for HIV/AIDS and TB, University of the Witwatersrand, South Africa, Johns Hopkins Center for Tuberculosis Research, Johns Hopkins University, Baltimore, MD, USA 6: Department of Epidemiology, Department of Epidemiology International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, Johns Hopkins Center for Tuberculosis Research, Johns Hopkins University, Baltimore, MD, USA
Publication date: 01 November 2019
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites